HealthThe first ever vaccine against RSV could be approved in 2023 Although usually mild, the respiratory syncytial virus can be fatal among babies and older people. Promising results from trials during pregnancy and in those aged 60 or over suggest that a vaccine may soon be approved Analysis
HealthVaccines that prolong the immune response may give better protection Most vaccines are designed to provoke a quick immune response, but a longer one might allow the most effective immune cells to stick around in the bone marrow News